Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+110.3%
5Y CAGR+59.3%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+110.3%/yr
vs -28.2%/yr prior
5Y CAGR
+59.3%/yr
Recent acceleration
Acceleration
+138.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.65M | +23.1% |
| 2024 | $9.46M | +10.8% |
| 2023 | $8.54M | +581.9% |
| 2022 | $1.25M | +1191.8% |
| 2021 | $97000.00 | -91.4% |
| 2020 | $1.13M | -81.3% |
| 2019 | $6.05M | +28.2% |
| 2018 | $4.72M | +792.1% |
| 2017 | $529000.00 | +713.8% |
| 2016 | $65000.00 | - |